Lv11
30 积分 2026-03-01 加入
Protein post-translational modifications and tumor immunity: A pan-cancer perspective
13小时前
待确认
[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma]
3个月前
已完结
ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function
3个月前
已完结
皖公网安备34019202002308
